A detailed history of Shelton Capital Management transactions in Organon & Co. stock. As of the latest transaction made, Shelton Capital Management holds 10,905 shares of OGN stock, worth $173,062. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,905
Previous 10,905 -0.0%
Holding current value
$173,062
Previous $225,000 7.56%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$17.45 - $21.96 $12,668 - $15,942
-726 Reduced 6.24%
10,905 $225,000
Q1 2024

May 15, 2024

BUY
$13.78 - $18.8 $160,275 - $218,662
11,631 New
11,631 $218,000
Q4 2023

Feb 14, 2024

BUY
$10.95 - $17.32 $137,159 - $216,950
12,526 New
12,526 $180,000
Q4 2021

Feb 11, 2022

SELL
$28.67 - $37.13 $246,820 - $319,652
-8,609 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$28.63 - $35.64 $25,595 - $31,862
-894 Reduced 9.41%
8,609 $282,000
Q2 2021

Aug 12, 2021

BUY
$28.45 - $38.0 $270,360 - $361,114
9,503 New
9,503 $288,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.04B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Shelton Capital Management Portfolio

Follow Shelton Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.